Takeharu Enomoto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Takeharu Enomoto has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
- Takehito Otsubo
Department of Gastroenterological and General Surgery, St. Marianna University School of Medicine, Kawasaki, Japan
7 shared publications Joe Sakurai
St. Marianna University School of Medicine
4 shared publicationsShinya Mikami
St Marianna Univ, Sch Med, Dept Gastrointestinal & Gen Surg, Kawasaki, Japan
4 shared publicationsTakehito Otsubo
St Marianna Univ, Dept Gastroenterol & Gen Surg, Sch Med, Kawasaki, Japan
3 shared publicationsToshiyuki Suwa
3 shared publicationsAkiyoshi Noda
2 shared publications
Latest Publications
- Open Access
- 3 November 2026
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
Late-onset erysipelas-like cutaneous metastasis of gastric cancer involving the genital and umbilical regions: a case report
Introduction and importance: Cutaneous metastasis from gastric cancer is a rare clinical event, typically signifying advanced disease. Carcinoma erysipeloides (CE) is a subtype of inflammatory cutaneous metastasis that often presents similarly to infectious lesions, such as cellulitis. Delayed-onset CE in highly atypical locations, such as the genital region, is exceptionally uncommon and poses a significant diagnostic challenge. Case presentation: A 70-year-old woman who underwent laparoscopic distal gastrectomy for Stage IB gastric cancer 6 years prior presented with a 3-month history of painful, dark-red swelling in the genital region. She was initially treated for suspected cellulitis with antibiotics; however, the lesions were refractory to therapy. Computed tomography revealed increased subcutaneous fat density in the genital region and an umbilical mass. A skin biopsy confirmed metastatic signet-ring cell carcinoma consistent with the patient’s primary gastric cancer. She was diagnosed with cutaneous metastasis following surgery for gastric cancer and received 14 cycles of modified folinic acid, fluorouracil, and oxaliplatin 6 chemotherapy, achieving marked clinical improvement. The patient remains in complete remission 22 months after completing treatment. Clinical discussion: This case is notable for its unusually long 6-year disease-free interval and rare metastatic involvement of the genital region. While CE usually involves the trunk or neck, our literature review suggests this may be the first documented case of erysipelas-like metastasis to the genital region from gastric cancer. Conclusion: During follow-up after surgery for gastric cancer, clinicians should consider this metastatic pattern and promptly perform a biopsy of inflammatory skin lesions that are resistant to treatment.
- 3 November 2026
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
Open AccessLate-onset erysipelas-like cutaneous metastasis of gastric cancer involving the genital and umbilical regions: a case report
Introduction and importance: Cutaneous metastasis from gastric cancer is a rare clinical event, typically signifying advanced disease. Carcinoma erysipeloides (CE) is a subtype of inflammatory cutaneous metastasis that often presents similarly to infectious lesions, such as cellulitis. Delayed-onset CE in highly atypical locations, such as the genital region, is exceptionally uncommon and poses a significant diagnostic challenge. Case presentation: A 70-year-old woman who underwent laparoscopic distal gastrectomy for Stage IB gastric cancer 6 years prior presented with a 3-month history of painful, dark-red swelling in the genital region. She was initially treated for suspected cellulitis with antibiotics; however, the lesions were refractory to therapy. Computed tomography revealed increased subcutaneous fat density in the genital region and an umbilical mass. A skin biopsy confirmed metastatic signet-ring cell carcinoma consistent with the patient’s primary gastric cancer. She was diagnosed with cutaneous metastasis following surgery for gastric cancer and received 14 cycles of modified folinic acid, fluorouracil, and oxaliplatin 6 chemotherapy, achieving marked clinical improvement. The patient remains in complete remission 22 months after completing treatment. Clinical discussion: This case is notable for its unusually long 6-year disease-free interval and rare metastatic involvement of the genital region. While CE usually involves the trunk or neck, our literature review suggests this may be the first documented case of erysipelas-like metastasis to the genital region from gastric cancer. Conclusion: During follow-up after surgery for gastric cancer, clinicians should consider this metastatic pattern and promptly perform a biopsy of inflammatory skin lesions that are resistant to treatment.
- Open Access
- 13 May 2024
- Published by Springer Nature in Cureus
- Vol. 16 (5) , e60178
Ten-Year Follow-Up After Chemotherapy and Conversion Surgery for Human Epidermal Growth Factor Receptor 2-Positive Stage IV Esophagogastric Junction Cancer With a Pathological Complete Response: A Case Report
Recent reports have focused on the usefulness of conversion surgery, in which chemotherapy is given to patients with unresectable advanced gastric cancer (GC), and radical surgery is subsequently performed if resection becomes possible; however, no consensus has been reached regarding the usefulness of this strategy. We report on a 74-year-old man who was diagnosed with esophagogastric junction cancer (T3N3M1 (LYM): stage IV). Chemotherapy was chosen and seven courses of S1 + cisplatin (SP) + trastuzumab (HCN) and two courses of S1 + HCN were administered. Approximately 10 months after the start of chemotherapy, the tumor had almost disappeared and we therefore decided to perform conversion surgery. Pathologic examination of the specimen and dissected lymph nodes showed no cancer. Postoperatively, the patient underwent chemotherapy until the second postoperative year, and no metastasis or recurrence was observed for nine years after surgery. Conversion surgery after chemotherapy resulted in recurrence-free survival in this case; however, further studies are needed to elucidate the effect of surgery after chemotherapy for patients with stage IV GC, as chemotherapy continues to evolve.
- 13 May 2024
- Published by Springer Nature in Cureus
- Vol. 16 (5) , e60178
Open AccessTen-Year Follow-Up After Chemotherapy and Conversion Surgery for Human Epidermal Growth Factor Receptor 2-Positive Stage IV Esophagogastric Junction Cancer With a Pathological Complete Response: A Case Report
Recent reports have focused on the usefulness of conversion surgery, in which chemotherapy is given to patients with unresectable advanced gastric cancer (GC), and radical surgery is subsequently performed if resection becomes possible; however, no consensus has been reached regarding the usefulness of this strategy. We report on a 74-year-old man who was diagnosed with esophagogastric junction cancer (T3N3M1 (LYM): stage IV). Chemotherapy was chosen and seven courses of S1 + cisplatin (SP) + trastuzumab (HCN) and two courses of S1 + HCN were administered. Approximately 10 months after the start of chemotherapy, the tumor had almost disappeared and we therefore decided to perform conversion surgery. Pathologic examination of the specimen and dissected lymph nodes showed no cancer. Postoperatively, the patient underwent chemotherapy until the second postoperative year, and no metastasis or recurrence was observed for nine years after surgery. Conversion surgery after chemotherapy resulted in recurrence-free survival in this case; however, further studies are needed to elucidate the effect of surgery after chemotherapy for patients with stage IV GC, as chemotherapy continues to evolve.
- Open Access
- 5 April 2024
- Published by Springer Nature in Updates in Surgery
- Vol. 76 (6) , 2285-2292
Retrospective observational cohort study of laparoscopic surgical strategies for gastrointestinal stromal tumors
Laparoscopic surgery has been used to treat gastric submucosal tumors (SMTs). Laparoscopic and endoscopic cooperative surgery (LECS) has been used when subtotal resection has been difficult, which enabled resection of these tumors. In this study, we reviewed the medical records of patients with gastric SMTs who underwent laparoscopic surgery in our hospital with the aim of reporting the surgical indications, procedures (especially for LECS), and outcomes of surgery. This study involved 55 patients who underwent laparoscopic surgery between April 2014 and March 2021. We classified the patients into two groups: laparoscopy-assisted surgery group (non-LECS group, n = 30) and LECS group (n = 25). LECS was performed in the upper stomach, in the greater curvature of the lower stomach, and in both intraluminal and intramural locations in the middle stomach. Non-LECS was selected for extraluminal and intramural tumors in the greater curvature of the upper stomach. There were no severe complications associated with the operation. There was one postoperative complication in the LECS group. The length of postoperative hospital stay did not significantly differ between the LECS and non-LECS groups. We reported the surgical procedures for gastric SMTs in our hospital. It is essential to make full use of the multiple techniques reported in this article and examine the location of the tumor to avoid excess or insufficient resection. Our review of the present case series allowed us to select the appropriate surgical approach for gastric SMTs based on the lesion location and type of development.
- 5 April 2024
- Published by Springer Nature in Updates in Surgery
- Vol. 76 (6) , 2285-2292
Open AccessRetrospective observational cohort study of laparoscopic surgical strategies for gastrointestinal stromal tumors
Laparoscopic surgery has been used to treat gastric submucosal tumors (SMTs). Laparoscopic and endoscopic cooperative surgery (LECS) has been used when subtotal resection has been difficult, which enabled resection of these tumors. In this study, we reviewed the medical records of patients with gastric SMTs who underwent laparoscopic surgery in our hospital with the aim of reporting the surgical indications, procedures (especially for LECS), and outcomes of surgery. This study involved 55 patients who underwent laparoscopic surgery between April 2014 and March 2021. We classified the patients into two groups: laparoscopy-assisted surgery group (non-LECS group, n = 30) and LECS group (n = 25). LECS was performed in the upper stomach, in the greater curvature of the lower stomach, and in both intraluminal and intramural locations in the middle stomach. Non-LECS was selected for extraluminal and intramural tumors in the greater curvature of the upper stomach. There were no severe complications associated with the operation. There was one postoperative complication in the LECS group. The length of postoperative hospital stay did not significantly differ between the LECS and non-LECS groups. We reported the surgical procedures for gastric SMTs in our hospital. It is essential to make full use of the multiple techniques reported in this article and examine the location of the tumor to avoid excess or insufficient resection. Our review of the present case series allowed us to select the appropriate surgical approach for gastric SMTs based on the lesion location and type of development.
- Open Access
- 1 January 2024
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 114 (C) , 109183
Presentation of unruptured right gastric aneurysm due to segmental arterial mediolysis resected laparoscopically: A case report
Introduction: Timely diagnosis and treatment of intra-abdominal arterial aneurysms before rupture are highly recommended. We successfully prevented rupture through arterial aneurysm excision, highlighting the importance of the lack of reports on resection before rupture. Case presentation: A 60-year-old male with previous history of ureteral stones presented complaining primarily of left-sided abdominal pain. Computed tomography (CT) revealed a left ureteral stone and incidentally identified a submucosal gastric tumor and right gastric artery aneurysm, leading to referral to our department. Blood tests showed no abnormalities. CT revealed a 23-mm submucosal tumor protruding outward from the middle gastric body wall. A 13-mm aneurysm was observed in the right gastric artery, and no other aneurysms were detected, including intracranially. Upper gastrointestinal endoscopy revealed a smooth elevation covered by normal mucosa in the middle gastric body. Endoscopic ultrasound-fine needle aspiration resulted in a diagnosis of gastrointestinal stromal tumor (GIST) and surgery. We performed simultaneous surgery involving laparoscopic local resection of the gastric GIST and identification and excision of the right gastric artery aneurysm due to its enlargement (7 mm on CT conducted six years ago). The patient's postoperative course was uneventful, and he was discharged on postoperative day 6. Pathological examination confirmed a diagnosis of segmental arterial mediolysis. Discussion: Intra-abdominal arterial aneurysms affect approximately 1 % of the population. Splenic artery aneurysms are the most common at 58.7 %, whereas the gastric artery and gastroepiploic artery account for only 4.7 %. Conclusion: Right gastric artery aneurysms are exceedingly rare, with no reported cases of successful resection before rupture. Highlights:
- 1 January 2024
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 114 (C) , 109183
Open AccessPresentation of unruptured right gastric aneurysm due to segmental arterial mediolysis resected laparoscopically: A case report
Introduction: Timely diagnosis and treatment of intra-abdominal arterial aneurysms before rupture are highly recommended. We successfully prevented rupture through arterial aneurysm excision, highlighting the importance of the lack of reports on resection before rupture. Case presentation: A 60-year-old male with previous history of ureteral stones presented complaining primarily of left-sided abdominal pain. Computed tomography (CT) revealed a left ureteral stone and incidentally identified a submucosal gastric tumor and right gastric artery aneurysm, leading to referral to our department. Blood tests showed no abnormalities. CT revealed a 23-mm submucosal tumor protruding outward from the middle gastric body wall. A 13-mm aneurysm was observed in the right gastric artery, and no other aneurysms were detected, including intracranially. Upper gastrointestinal endoscopy revealed a smooth elevation covered by normal mucosa in the middle gastric body. Endoscopic ultrasound-fine needle aspiration resulted in a diagnosis of gastrointestinal stromal tumor (GIST) and surgery. We performed simultaneous surgery involving laparoscopic local resection of the gastric GIST and identification and excision of the right gastric artery aneurysm due to its enlargement (7 mm on CT conducted six years ago). The patient's postoperative course was uneventful, and he was discharged on postoperative day 6. Pathological examination confirmed a diagnosis of segmental arterial mediolysis. Discussion: Intra-abdominal arterial aneurysms affect approximately 1 % of the population. Splenic artery aneurysms are the most common at 58.7 %, whereas the gastric artery and gastroepiploic artery account for only 4.7 %. Conclusion: Right gastric artery aneurysms are exceedingly rare, with no reported cases of successful resection before rupture. Highlights:
- Open Access
- 21 November 2023
- Published by Springer Nature in Research Square
Ten-year follow-up after chemotherapy (S1 + cisplatin + trastuzumab) and surgery for human epidermal growth factor receptor 2-positive stage IV esophagogastric junction cancer with pathological complete response: a case report
Background: In recent years, many reports have focused on the usefulness of conversion surgery, in which chemotherapy is given to patients with unresectable advanced gastric cancer (GC) and radical surgery is performed if resection becomes possible. However, no consensus has been reached regarding the usefulness of this strategy. Case presentation: A 74-year-old man was diagnosed with GC after experiencing abdominal pain. Esophagogastroduodenoscopy revealed an elevated lesion with ulceration at the esophagogastric junction (40 mm in size, type 1 gross type), and biopsy revealed well-differentiated adenocarcinoma. Chest and abdominal computed tomography showed wall thickening at the hilum and multiple enlarged lymph nodes in the left supraclavicular fossa and around the aorta from the hilum to the upper abdomen. These findings were consistent with a malignant tumor at the esophagogastric junction, and esophagogastric junction cancer was diagnosed [T3N3M1 (LYM): stage IV]. Chemotherapy was chosen, and seven courses of S1 + cisplatin (SP) + trastuzumab (HCN) were administered. The patient developed neuropathy, and two courses of S1 + HCN were administered. Approximately 10 months after the start of chemotherapy, upper gastrointestinal endoscopy and positron emission tomography/computed tomography showed that the tumor was almost gone; therefore, we decided to perform conversion surgery. The patient underwent open total gastrectomy, D2 lymph node dissection, and Roux-en-Y reconstruction. Scarring at the esophageal junction was evident on palpation of the specimen, but pathologic examination of the specimen and dissected lymph nodes showed no cancer. Postoperatively, the patient underwent 2 cycles of S1 + HCN followed by 48 cycles of HCN until the second postoperative year. No metastasis or recurrence was observed for 9 years after surgery. Conclusions: We have reported a case of stage IV esophagogastric junction cancer with a pathological complete response obtained by SP + HCN therapy. Conversion surgery after chemotherapy resulted in recurrence-free survival. However, further study is needed to elucidate the effect of surgery on top of chemotherapy for stage IV GC as chemotherapy continues to evolve.
- 21 November 2023
- Published by Springer Nature in Research Square
Open AccessTen-year follow-up after chemotherapy (S1 + cisplatin + trastuzumab) and surgery for human epidermal growth factor receptor 2-positive stage IV esophagogastric junction cancer with pathological complete response: a case report
Background: In recent years, many reports have focused on the usefulness of conversion surgery, in which chemotherapy is given to patients with unresectable advanced gastric cancer (GC) and radical surgery is performed if resection becomes possible. However, no consensus has been reached regarding the usefulness of this strategy. Case presentation: A 74-year-old man was diagnosed with GC after experiencing abdominal pain. Esophagogastroduodenoscopy revealed an elevated lesion with ulceration at the esophagogastric junction (40 mm in size, type 1 gross type), and biopsy revealed well-differentiated adenocarcinoma. Chest and abdominal computed tomography showed wall thickening at the hilum and multiple enlarged lymph nodes in the left supraclavicular fossa and around the aorta from the hilum to the upper abdomen. These findings were consistent with a malignant tumor at the esophagogastric junction, and esophagogastric junction cancer was diagnosed [T3N3M1 (LYM): stage IV]. Chemotherapy was chosen, and seven courses of S1 + cisplatin (SP) + trastuzumab (HCN) were administered. The patient developed neuropathy, and two courses of S1 + HCN were administered. Approximately 10 months after the start of chemotherapy, upper gastrointestinal endoscopy and positron emission tomography/computed tomography showed that the tumor was almost gone; therefore, we decided to perform conversion surgery. The patient underwent open total gastrectomy, D2 lymph node dissection, and Roux-en-Y reconstruction. Scarring at the esophageal junction was evident on palpation of the specimen, but pathologic examination of the specimen and dissected lymph nodes showed no cancer. Postoperatively, the patient underwent 2 cycles of S1 + HCN followed by 48 cycles of HCN until the second postoperative year. No metastasis or recurrence was observed for 9 years after surgery. Conclusions: We have reported a case of stage IV esophagogastric junction cancer with a pathological complete response obtained by SP + HCN therapy. Conversion surgery after chemotherapy resulted in recurrence-free survival. However, further study is needed to elucidate the effect of surgery on top of chemotherapy for stage IV GC as chemotherapy continues to evolve.
- 1 January 2017
- Published by Japan Surgical Association in Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
- Vol. 78 (2) , 321-326
A Case of Pyogenic Granuloma of the Ileum Presenting with Severe Anemia
症例は40歳,男性.黒色便とめまいを認め,前医を受診.血液検査でHb 6.2g/dlと貧血を認め,造影CTで小腸出血が疑われ当院搬送となった.再度施行したCTで造影剤の漏出は認めなかったが,7.5mmの造影効果に富む腫瘤を認め出血源と考えられた.小腸内視鏡では回腸に約10mm大の亜有茎性腫瘤を認めた.腫瘍から出血はなく,その後,貧血の進行を認めなかったため,上下部消化管内視鏡検査で他に出血源がないことを確認し,単孔式腹腔鏡補助下小腸部分切除術を施行.病理検査ではpyogenic granulomaと診断された.Pyogenic granulomaの消化管発生は極めて稀であり,小腸原発の本邦報告は自験例を含めわずか12例に過ぎない.本疾患の多くは高度貧血をきたすため,原因として念頭に置くと共に,ダイナミックCTから小腸内視鏡,そして鏡視下手術といった診断治療のアルゴリズムが有用と思われた.
- 1 January 2017
- Published by Japan Surgical Association in Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
- Vol. 78 (2) , 321-326
A Case of Pyogenic Granuloma of the Ileum Presenting with Severe Anemia
症例は40歳,男性.黒色便とめまいを認め,前医を受診.血液検査でHb 6.2g/dlと貧血を認め,造影CTで小腸出血が疑われ当院搬送となった.再度施行したCTで造影剤の漏出は認めなかったが,7.5mmの造影効果に富む腫瘤を認め出血源と考えられた.小腸内視鏡では回腸に約10mm大の亜有茎性腫瘤を認めた.腫瘍から出血はなく,その後,貧血の進行を認めなかったため,上下部消化管内視鏡検査で他に出血源がないことを確認し,単孔式腹腔鏡補助下小腸部分切除術を施行.病理検査ではpyogenic granulomaと診断された.Pyogenic granulomaの消化管発生は極めて稀であり,小腸原発の本邦報告は自験例を含めわずか12例に過ぎない.本疾患の多くは高度貧血をきたすため,原因として念頭に置くと共に,ダイナミックCTから小腸内視鏡,そして鏡視下手術といった診断治療のアルゴリズムが有用と思われた.
- Open Access
- 21 August 2010
- Published by Springer Nature in International Journal of Emergency Medicine
- Vol. 3 (4) , 503-504
Pneumocephalus as a complication of esophageal carcinoma
- 21 August 2010
- Published by Springer Nature in International Journal of Emergency Medicine
- Vol. 3 (4) , 503-504
Open AccessPneumocephalus as a complication of esophageal carcinoma
- 26 March 2010
- Published by Springer Nature in Surgery Today
- Vol. 40 (4) , 380-384
Mixed acinar-endocrine carcinoma of the pancreas with intraductal growth into the main pancreatic duct: Report of a case
The patient was a 75-year-old asymptomatic man, in whom a tumor mass in the pancreatic tail had been found 6 months earlier. Computed tomography revealed a mass 7 cm in diameter, and an enhancement with contrast medium was observed at the periphery and partially inside the mass, but not in most parts of the tumor. Endoscopic retrograde cholangiopancreatography showed a filling defect in the main pancreatic duct. A distal pancreatectomy was performed because of the possibility of a malignant tumor. The tumor consisted of a lobular invasive growth component and a component with intraductal growth into the main pancreatic duct, and histologically the tumor cells had solid acinar to partially trabecular/tubular patterns. Trypsin (an acinic cell marker) expression was widely observed, followed by the expression of chromogranin A (an endocrine cell marker) in about 30% of the tumor cells. The tumor was diagnosed as mixed acinar-endocrine carcinoma according to the WHO classification.
- 26 March 2010
- Published by Springer Nature in Surgery Today
- Vol. 40 (4) , 380-384
Mixed acinar-endocrine carcinoma of the pancreas with intraductal growth into the main pancreatic duct: Report of a case
The patient was a 75-year-old asymptomatic man, in whom a tumor mass in the pancreatic tail had been found 6 months earlier. Computed tomography revealed a mass 7 cm in diameter, and an enhancement with contrast medium was observed at the periphery and partially inside the mass, but not in most parts of the tumor. Endoscopic retrograde cholangiopancreatography showed a filling defect in the main pancreatic duct. A distal pancreatectomy was performed because of the possibility of a malignant tumor. The tumor consisted of a lobular invasive growth component and a component with intraductal growth into the main pancreatic duct, and histologically the tumor cells had solid acinar to partially trabecular/tubular patterns. Trypsin (an acinic cell marker) expression was widely observed, followed by the expression of chromogranin A (an endocrine cell marker) in about 30% of the tumor cells. The tumor was diagnosed as mixed acinar-endocrine carcinoma according to the WHO classification.
- 1 April 2009
- Vol. 36 (4) , 667-70
[A case report of complete response to RPMI regimen for multiple lymph node metastases following rectal cancer surgery].
A 78-year old man underwent low anterior resection for Stage IIIb rectal cancer(Ra). After surgery, he underwent the Roswell Park Memorial Institute(RPMI)regimen for 6 months followed by oral UFT for 8 months. Since liver metastasis(S6)recurred 2 years and 2 months after surgery, he underwent S6 subsegmentectomy. Four years and 4 months later, he developed multiple lymph node metastases(the Virchow, paraaortic, and intrapelvic lymph nodes), for which FOLFIRI therapy was started, but converted to the RPMI regimen because of strong gastrointestinal side effects. After 3 courses of this regimen, tumor markers returned to normal, and imaging studies showed that the metastases had disappeared. This was interpreted as a complete response(CR). The patient has maintained the complete response for 1 year and 4 months since the start of the RPMI regimen.
- 1 April 2009
- Vol. 36 (4) , 667-70
[A case report of complete response to RPMI regimen for multiple lymph node metastases following rectal cancer surgery].
A 78-year old man underwent low anterior resection for Stage IIIb rectal cancer(Ra). After surgery, he underwent the Roswell Park Memorial Institute(RPMI)regimen for 6 months followed by oral UFT for 8 months. Since liver metastasis(S6)recurred 2 years and 2 months after surgery, he underwent S6 subsegmentectomy. Four years and 4 months later, he developed multiple lymph node metastases(the Virchow, paraaortic, and intrapelvic lymph nodes), for which FOLFIRI therapy was started, but converted to the RPMI regimen because of strong gastrointestinal side effects. After 3 courses of this regimen, tumor markers returned to normal, and imaging studies showed that the metastases had disappeared. This was interpreted as a complete response(CR). The patient has maintained the complete response for 1 year and 4 months since the start of the RPMI regimen.
- Open Access
- 1 January 2008
- Published by The Japanese Journal of Gastroenterological Surgery in The Japanese Journal of Gastroenterological Surgery
- Vol. 41 (12) , 2018-2022
A Case of Carcinomatosa Pericarditis from Gastric Cancer with Cardiac Tamponade Eight Years after a Surgical Treatment
症例は55歳の男性で, 主訴は咳漱, 食欲低下, 頸静脈怒脹と下腿浮腫. 平成6年10月に胃癌で胃全摘術, 胆嚢脾臓合併切除を施行した. 平成14年2月から主訴が出現し, 外来を受診した. 心嚢水貯留と心タンポナーデによる右心不全を認めたため, ただちに超音波ガイド下心嚢穿刺を施行した. 心嚢水の細胞診はclass Vであった. 多発性骨転移, 胸膜転移も認められたため, TS-1 (100mg/body/day) を開始した. TS-1投与1コース終了後の心嚢水細胞診は陰性化し, 骨転移数も著明に減少した. TS-1を3コース終了後に癌性胸膜炎の急速な進行と癌性リンパ管炎を併発し, 第229病日に永眠された. 胃癌による癌性心膜炎はまれであるが, 心タンポナーデの可能性も念頭におく必要があると思われた. また, TS-1が奏効したので治療の選択肢として考慮すべきであると考えられた.
- 1 January 2008
- Published by The Japanese Journal of Gastroenterological Surgery in The Japanese Journal of Gastroenterological Surgery
- Vol. 41 (12) , 2018-2022
Open AccessA Case of Carcinomatosa Pericarditis from Gastric Cancer with Cardiac Tamponade Eight Years after a Surgical Treatment
症例は55歳の男性で, 主訴は咳漱, 食欲低下, 頸静脈怒脹と下腿浮腫. 平成6年10月に胃癌で胃全摘術, 胆嚢脾臓合併切除を施行した. 平成14年2月から主訴が出現し, 外来を受診した. 心嚢水貯留と心タンポナーデによる右心不全を認めたため, ただちに超音波ガイド下心嚢穿刺を施行した. 心嚢水の細胞診はclass Vであった. 多発性骨転移, 胸膜転移も認められたため, TS-1 (100mg/body/day) を開始した. TS-1投与1コース終了後の心嚢水細胞診は陰性化し, 骨転移数も著明に減少した. TS-1を3コース終了後に癌性胸膜炎の急速な進行と癌性リンパ管炎を併発し, 第229病日に永眠された. 胃癌による癌性心膜炎はまれであるが, 心タンポナーデの可能性も念頭におく必要があると思われた. また, TS-1が奏効したので治療の選択肢として考慮すべきであると考えられた.